CDX2 Expression and Prognostic Factors of Resectable Pulmonary Large Cell Neuroendocrine Carcinoma

BACKGROUND AND AIM: Pulmonary large cell neuroendocrine carcinoma (LCNEC) is a rare neoplasm, and its clinical features and management are still limited. We evaluated the clinicopathological factors, including CDX2 immunohistochemical expression, to predict survival in patients with LCNEC. PATIENTS...

Descripción completa

Detalles Bibliográficos
Autores principales: Mori, Ryo, Yamashita, Shin-ichi, Midorikawa, Kensuke, Abe, Sosei, Inada, Kazuo, Yoneda, Satoshi, Okabayashi, Kan, Nabeshima, Kazuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705386/
https://www.ncbi.nlm.nih.gov/pubmed/33293882
http://dx.doi.org/10.1177/1179554920967319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705386/
https://www.ncbi.nlm.nih.gov/pubmed/33293882
http://dx.doi.org/10.1177/1179554920967319

Ejemplares similares